@article{555c21101771409fbda6a3754041d87c,
title = "NSABP B-42: A clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging disease-free survival in postmenopausal women with hormone receptor-positive breast cancer",
keywords = "Arterial thrombotic events, Duration of therapy, Early-stage disease, Osteoporotic fracture",
author = "Mamounas, {Eleftherios P.} and Barry Lembersky and Jeong, {Jong Hyeon} and Walter Cronin and Barbara Harkins and Charles Geyer and Wickerham, {Donald Lawrence} and Soonmyung Paik and Joseph Costantino and Norman Wolmark",
note = "Funding Information: This work is supported in part by Public Health Service Grants U10CA-12027, U10CA-69974, U10CA-37377, and U10CA-69651 from the National Cancer Institute, Department of Health and Human Services. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.",
year = "2006",
month = dec,
doi = "10.3816/CBC.2006.n.061",
language = "English (US)",
volume = "7",
pages = "416--421",
journal = "Clinical Breast Cancer",
issn = "1526-8209",
publisher = "Elsevier",
number = "5",
}